國立虎尾科技大學 |

Law and Economics of Personalized Medicine = Institutional Levers to Foster the Translation of Personalized Medicine /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Law and Economics of Personalized Medicine/ by Karin Bosshard.
Reminder of title:	Institutional Levers to Foster the Translation of Personalized Medicine /
Author:	Bosshard, Karin.
Description:	XXXVI, 411 p. 41 illus., 7 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Law and economics. -
Online resource:	https://doi.org/10.1007/978-3-658-22074-7
ISBN:	9783658220747

Law and Economics of Personalized Medicine = Institutional Levers to Foster the Translation of Personalized Medicine /
Bosshard, Karin.

Law and Economics of Personalized MedicineInstitutional Levers to Foster the Translation of Personalized Medicine /[electronic resource] :by Karin Bosshard. - 1st ed. 2018. - XXXVI, 411 p. 41 illus., 7 illus. in color.online resource. - Gesundheitsmanagement und Gesundheitsökonomik,2523-7667. - Gesundheitsmanagement und Gesundheitsökonomik,.

Overview of terminologies used in the context of personalized medicine -- Description of personalized medicine’s impact on the healthcare landscape -- Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice -- Analysis of institutional barriers to the translation of personalized medicine in Switzerland -- Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice.

The book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the barriers. An applied part identifies and evaluates policy levers to foster the translation of personalized medicine into Swiss clinical practice. The content • Overview of terminologies used in the context of personalized medicine • Description of personalized medicine’s impact on the healthcare landscape • Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice • Analysis of institutional barriers to the translation of personalized medicine in Switzerland • Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice Target groups • Social scientists with limited knowledge of personalized medicine, Law and Economics scholars, health economists • Practitioners in pharmaceutical, diagnostics and health insurance companies, healthcare policy makers and Swiss lawyers The author Dr. Karin Bosshard wrote this book during her time with a globally leading management consultancy where she was working as a strategy consultant. The author is currently working at an international pharmaceutical and diagnostics company and is a lecturer at the University of St. Gallen.

ISBN: 9783658220747

Standard No.: 10.1007/978-3-658-22074-7doiSubjects--Topical Terms:

560301
Law and economics.

LC Class. No.: HB73

Dewey Class. No.: 330

Law and Economics of Personalized Medicine = Institutional Levers to Foster the Translation of Personalized Medicine /
LDR:03516nam a22004095i 4500 001 986876
003 DE-He213
005 20200704090548.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783658220747 $9 978-3-658-22074-7
024 7 $a 10.1007/978-3-658-22074-7 $2 doi
035 $a 978-3-658-22074-7
050 4 $a HB73
072 7 $a LBBM $2 bicssc
072 7 $a LAW014000 $2 bisacsh
072 7 $a LBBM $2 thema
072 7 $a LNC $2 thema
082 0 4 $a 330 $2 23
100 1 $a Bosshard, Karin. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1204623
245 1 0 $a Law and Economics of Personalized Medicine $h [electronic resource] : $b Institutional Levers to Foster the Translation of Personalized Medicine / $c by Karin Bosshard.
250 $a 1st ed. 2018.
264 1 $a Wiesbaden : $b Springer Fachmedien Wiesbaden : $b Imprint: Springer Gabler, $c 2018.
300 $a XXXVI, 411 p. 41 illus., 7 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Gesundheitsmanagement und Gesundheitsökonomik, $x 2523-7667
505 0 $a Overview of terminologies used in the context of personalized medicine -- Description of personalized medicine’s impact on the healthcare landscape -- Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice -- Analysis of institutional barriers to the translation of personalized medicine in Switzerland -- Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice.
520 $a The book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the barriers. An applied part identifies and evaluates policy levers to foster the translation of personalized medicine into Swiss clinical practice. The content • Overview of terminologies used in the context of personalized medicine • Description of personalized medicine’s impact on the healthcare landscape • Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice • Analysis of institutional barriers to the translation of personalized medicine in Switzerland • Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice Target groups • Social scientists with limited knowledge of personalized medicine, Law and Economics scholars, health economists • Practitioners in pharmaceutical, diagnostics and health insurance companies, healthcare policy makers and Swiss lawyers The author Dr. Karin Bosshard wrote this book during her time with a globally leading management consultancy where she was working as a strategy consultant. The author is currently working at an international pharmaceutical and diagnostics company and is a lecturer at the University of St. Gallen.
650 0 $a Law and economics. $3 560301
650 0 $a Evolutionary economics. $3 555263
650 0 $a Health economics. $2 bicssc $3 810102
650 1 4 $a Law and Economics. $3 669261
650 2 4 $a Institutional/Evolutionary Economics. $3 1106534
650 2 4 $a Health Economics. $3 786205
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783658220730
776 0 8 $i Printed edition: $z 9783658220754
830 0 $a Gesundheitsmanagement und Gesundheitsökonomik, $x 2523-7667 $3 1279398
856 4 0 $u https://doi.org/10.1007/978-3-658-22074-7
912 $a ZDB-2-ECF
912 $a ZDB-2-SXEF
950 $a Economics and Finance (SpringerNature-41170)
950 $a Economics and Finance (R0) (SpringerNature-43720)